Loading...
The Off-Patent Biological Market in Belgium: Is the Health System Creating a Hurdle to Fair Market Competition?
We investigated the off-patent biological market in Belgium from a policy maker’s perspective, in light of the Belgian pharmaceutical health system. The main barriers relate to a short-term budgetary focus, to the overwhelming innovator’s reach and to a concertation model with assessment and apprais...
Na minha lista:
| Udgivet i: | Pharmaceuticals (Basel) |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8069942/ https://ncbi.nlm.nih.gov/pubmed/33920150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14040352 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|